4
Changes in Ownership
Lycia Therapeutics, Inc. Filed Acc 0002159565-26-000005
Options or other derivatives
- Chief Scientific Officer acquired 110,896 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Staben Steven Chief Scientific Officer | 2026-08-11 | Grant or award · Stock Option (Right to Buy) | +110,896 | 110,896 | D | ||
Loading xslF345X06/form4-10262026_111030.xml…